Mural Oncology plc
MURA
$2.09
-$0.01-0.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.09% | -17.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.81% | -4.10% | |||
| Operating Income | 8.81% | 4.10% | |||
| Income Before Tax | -44.80% | 3.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -44.80% | 3.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -44.80% | 3.32% | |||
| EBIT | 8.81% | 4.10% | |||
| EBITDA | 9.89% | 4.15% | |||
| EPS Basic | -43.94% | 3.87% | |||
| Normalized Basic EPS | 8.51% | 3.88% | |||
| EPS Diluted | -43.94% | 3.87% | |||
| Normalized Diluted EPS | 8.51% | 3.88% | |||
| Average Basic Shares Outstanding | 0.60% | 0.58% | |||
| Average Diluted Shares Outstanding | 0.60% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||